Eli Lilly and Company is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The following document cites that the company conducts animal testing to assess a product’s safety profile.
“FDA requested the drug’s manufacturer, Eli Lilly and Company, to conduct an animal study to test whether movement of olanzapine into blood after death could lead to higher-than-expected blood levels of the drug.” Read the full document.
With the help of PETA supporters who held stock in Eli Lilly, a resolution was filed in the fall of 2004 calling on the company to “Give the Animals 5“—replace five crude and cruel animal tests with state-of-the-art and scientifically valid non-animal methods that were already in use in other countries.
Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company’s Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company’s animal health products segment includes products for food animals and products for companion animals. [Source: GoogleFinance]
Company Website: https://www.lilly.com